pharmatechoutlook
FEBRUARY 20245TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSConsiderations for Clinical In-Use Testing of BiotherapeuticsLéa Sorret,Principal Scientist & Group Lead in PharmaceuticalDevelopment,Lonza18Technological advancements for industrial revolution 4.0Alessandro Gazzotti,Operations Director,Bormioli Pharma20MACHINE-LEARNING-GENERATED INSIGHTS FROM HEALTH DATA: PROMISE OF NATURAL LANGUAGE PROCESSINGKim Wager,Scientific Director,Oxford PharmaGenesis22RE-THINKING THE PHARMACEUTICAL VALUE CHAIN Ivanna M. Rosendal,Senior Director, IT Business Partner,Ascendis Pharma16Driving Innovation and Collaboration in the Pharmaceutical IndustryPatrick Nieuwenhuizen,Director / Principal Consultant,PharmaLex24The Tipping Point for Scalable Manufacturing Processes to Pivot Gene TherapiesDr Linda Randall,Associate Vice President, Biologics Development,Manufacturing and Control,Pharmarons26TOP 10 TECH OUTLOOKPHARMACEUTICALSOLUTIONS PROVIDERS IN UK - 2024PG 28
< Page 4 | Page 6 >